FIRST TRUST ADVISORS LP

Position in BEAM — Beam Therapeutics Inc.

CIK 1125816 Wheaton, IL

Position in BEAM

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$6,141,392

+$2,920,387 QoQ

Shares Held

178,945

+32.4% QoQ

Ownership

0.173%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#49

of 274 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. BEAM ranks #60 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	547,132	$341,158,687
2	INCY	Incyte Corp	1,587,996	$180,015,226
3	CORT	Corcept Therapeutics Inc	1,829,545	$159,078,937
4	VRTX	Vertex Pharmaceuticals Inc / Ma	289,179	$143,643,884
5	EXEL	Exelixis, Inc.	2,543,353	$138,383,836
6	ALNY	Alnylam Pharmaceuticals, Inc.	421,534	$126,894,380
7	KRYS	Krystal Biotech, Inc.	324,900	$120,755,583
8	AXSM	Axsome Therapeutics, Inc.	482,061	$117,994,070

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,141,392	178,945	+32.4%	Shares	Sole	2026-08-11
2026-03-31	$3,221,005	135,166	+111.0%	Shares	Sole	2026-05-13
2025-12-31	$1,775,632	64,056	-35.4%	Shares	Sole	2026-02-13
2025-03-31	$1,935,110	99,084	+287.1%	Shares	Sole	2025-05-14
2024-12-31	$634,756	25,595	+42.4%	Shares	Sole	2025-02-13
2024-09-30	$440,314	17,972	-98.8%	Shares	Sole	2024-11-13
2024-06-30	$34,729,609	1,482,271	+2718.9%	Shares	Sole	2024-08-13
2022-12-31	$2,056,560	52,584	+561.0%	Shares	Sole	2023-02-09
2022-03-31	$455,821	7,955	-9.9%	Shares	Sole	2022-05-13
2021-12-31	$703,662	8,830	-89.6%	Shares	Sole	2022-02-08
2021-09-30	$7,405,073	85,106	+38.7%	Shares	Sole	2021-11-15
2021-06-30	$7,895,200	61,341	—	Shares	Sole	2021-10-12
No filing history on record for this holder in this stock.